Viability and Potency of post thaw cells is becoming an increasingly relevant topic in areas such as in vitro drug screening and cell therapies. A new article comparing these two parameters - in a passive cryo container and a controlled rate freezer (Planer Kryo) - has just been published in BioProcess magazine.

The article was written by Dr Tamara Lekishvili of LGC, the UK National Measurement Institute for chemical and biological metrology, and Dr Marc-Olivier Baradez from the Cell Therapy Catapult, a recent government initiative aiming to become a global leader in the development, delivery and commercialisation of cell therapy. The Cell Therapy Catapult recently bought a freezer from us for their base at Guys Hospital in London for stem cell banks and cell product freezing.

The Cell Therapy Catapult aims to accelerate translational innovations in the fast growing field of cell and gene therapies with projects that range from platform development for scaling up cell production for clinical trials to building a state-of-the-art manufacturing centre allowing UK and worldwide companies to plan for their GMP (Good Manufacturing Practice) manufacturing base in Europe

For further information
http://planer.com/company/news/latest-news/698-variables-in-passive-cryopreservative-methods-standardizing-cell-based-assays-by-reducing-cryopreservation-induced-variability.html